.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Argus Health
Merck
Healthtrust
UBS
Farmers Insurance
Daiichi Sankyo
Harvard Business School
Boehringer Ingelheim
Federal Trade Commission

Generated: December 15, 2017

DrugPatentWatch Database Preview

VICOPROFEN Drug Profile

« Back to Dashboard

When do Vicoprofen patents expire, and when can generic versions of Vicoprofen launch?

Vicoprofen is a drug marketed by Abbvie and is included in one NDA. There are two patents protecting this drug and two Paragraph IV challenges.

The generic ingredient in VICOPROFEN is hydrocodone bitartrate; ibuprofen. There are twenty-two drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the hydrocodone bitartrate; ibuprofen profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
AbbvieVICOPROFENhydrocodone bitartrate; ibuprofenTABLET;ORAL020716-001Sep 23, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
AbbvieVICOPROFENhydrocodone bitartrate; ibuprofenTABLET;ORAL020716-001Sep 23, 1997DISCNYesNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: VICOPROFEN

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
AbbvieVICOPROFENhydrocodone bitartrate; ibuprofenTABLET;ORAL020716-001Sep 23, 1997► Subscribe► Subscribe
AbbvieVICOPROFENhydrocodone bitartrate; ibuprofenTABLET;ORAL020716-001Sep 23, 1997► Subscribe► Subscribe
AbbvieVICOPROFENhydrocodone bitartrate; ibuprofenTABLET;ORAL020716-001Sep 23, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for VICOPROFEN

Drugname Dosage Strength RLD Submissiondate
hydrocodone bitartrate and ibuprofenTablets2.5 mg/200 mgVicoprofen2/24/2006
hydrocodone bitartrate and ibuprofenTablets5 mg/200 mgVicoprofen5/27/2005

Non-Orange Book Patents for Tradename: VICOPROFEN

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,833,547Ibuprofen and narcotic analgesic compositions► Subscribe
6,361,794 Method of making ibuprofen and narcotic analgesic composition► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
McKinsey
QuintilesIMS
Johnson and Johnson
Fuji
UBS
Boehringer Ingelheim
Cipla
US Army
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot